Literature DB >> 11797507

Joint accumulations of FDG in whole body PET scans.

G K von Schulthess1, N Meier, K D Stumpe.   

Abstract

PURPOSE: To retrospectively evaluate FDG accumulations in major joints in a large series of non-absorption corrected partial body and whole body FDG-PET scans, and to determine the frequency and intensity of accumulation.
MATERIALS AND METHODS: 354 consecutive PET partial- and whole body non-transmission corrected scans of patients obtained for tumor staging were examined with respect to FDG accumulations in the acromio-clavicular (AC)-, gleno-humeral-, hip-, knee- and talo-tibial joints. FDG-uptake was graded using a semi-quantitative scale from 0 (no accumulation) to 4 (very strong accumulation comparable to brain uptake).
RESULTS: Joint activity of grade 1-2 was noted frequently, while grade 3 was rare, occurring only in the knee and shoulder joints, and grade 4 was inexistent. The 43 patients with grade 3 accumulations or with at least 4 joints showing grade 2 uptake were interviewed, but all denied pain specifically referred to a joint. Joint accumulations were seen in 50% of the acromio-clavicular-, 80% in the glenohumeral-, 50% in the hip-, 90% in the knee and 80% in the talo-tibial joints. The intensities of joint accumulations correlated positively and significantly with patient age, ranging from r = 0.7 and p < 0.05 in the knee to r = 0.96 and p < 0.0001 in the AC joint.
CONCLUSIONS: FDG accumulations in the joints in whole body FDG-PET scans are frequent and are very likely not related to symptoms. As there is a strong age correlation, and FDG is known to accumulate in inflammatory lesions, the findings are most likely a result of sub-clinical inflammatory synovial proliferation or other chronic inflammatory processes occurring in aging joints.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797507

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  6 in total

1.  The value of FDG-PET in patients with painful total knee arthroplasty.

Authors:  Katrin D M Stumpe; Jose Romero; Oliver Ziegler; Ehab M Kamel; Gustav K von Schulthess; Klaus Strobel; Juerg Hodler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

Review 2.  False-positive FDG PET uptake--the role of PET/CT.

Authors:  Sandra J Rosenbaum; Thomas Lind; Gerald Antoch; Andreas Bockisch
Journal:  Eur Radiol       Date:  2005-12-17       Impact factor: 5.315

Review 3.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

4.  [18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.

Authors:  Ehab M Kamel; Matthias T Wyss; Mathias K Fehr; Gustav K von Schulthess; Gerhard W Goerres
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-12       Impact factor: 4.553

5.  2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.

Authors:  E H Elzinga; C J van der Laken; E F I Comans; A A Lammertsma; B A C Dijkmans; A E Voskuyl
Journal:  Mol Imaging Biol       Date:  2007 Nov-Dec       Impact factor: 3.488

Review 6.  Animal models of osteoarthritis: classification, update, and measurement of outcomes.

Authors:  Emmanuel L Kuyinu; Ganesh Narayanan; Lakshmi S Nair; Cato T Laurencin
Journal:  J Orthop Surg Res       Date:  2016-02-02       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.